Genomics, Cancer Care and Advocacy
by S.F. Terry, K. Zeitz, M.A. Majumder, P.F. Terry
Publisher: Genetic Alliance 2006
Number of pages: 29
In the past several decades, oncologists and cancer researchers have come to recognize the importance of the role of advocacy organizations in cancer research and treatment. With genomics poised to become a major force in cancer care, advocacy organizations have an important role to play in traditional areas of concern such as patient education about new genomic technologies.
Home page url
Download or read it online for free here:
by Paul J. Grippo, Hidayatullah G. Munshi - Transworld Research Network
Pancreatic adenocarcinoma is histologically characterized by a dense desmoplastic reaction surrounding malignant epithelial cells. The DR is composed of ECM proteins, fibroblasts, stellate cells, endothelial cells, immune cells, and neurons.
by S. Nass, H. Moses - National Academies Press
Many cancer patients are diagnosed at a stage in which the cancer is too far advanced to be cured. There is tremendous opportunity to improve the outcome for people with cancer by enhancing detection and treatment approaches.
by Raimundas Lunevicius - InTech
The era of therapy for GISTs is being proclaimed as bringing the message of special importance to the pathologist role in multidisciplinary team that are responsible for treating patients with locally advanced or metastatic GIST.
- National Academies Press
Genome-Based Diagnostics assesses the evidentiary requirements for clinical utility of molecular diagnostics used to guide treatment decisions for patients with cancer and considers innovative, sustainable research collaborations ...